Palbociclib
Also known as Ibrance (us), Palbace (india)
A CDK4/6 inhibitor used with hormone therapy for HR-positive, HER2-negative advanced breast cancer.
SMILES: CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
Based on 21 capsules 28-day cycle. US $744.24 vs India $10.50 per capsule.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $92,451
- Estimated travel cost
- − $2,300
- Net savings after travel
- $90,151
Even after travel, you could come out ahead by about $90,151.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Palbociclib is filled about 131.5K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.